Our results have shown an increase in the incidence of BC over the past thirty years, particularly affecting YW. It will be necessary to strengthen awareness campaigns on known modifiable risk factors and search for other potential risk factors such as environmental exposure. Progress is still needed in improving the identification of high-risk patients to increase the number of early diagnoses. Further research on the evaluation of personalized screening is required. In the meantime, the continuous improvement of survival thanks to new therapies brings important hope in the management of BC.
BC: Breast cancer; YW: Young women; BCYW : Breast cancer in young women; CI: Confidence interval; AAPC: Average annual percent change; ER: Estrogen receptor; PR: Progesterone receptor; HER2: Human epidermal growth factor receptor type 2.
Availability of data and materials
Data supporting the findings of this study are available upon request from the corresponding author.
Ethics approval and consent to participate
Our database is authorized by the National Commission for Information Technology and Freedom (CNIL), and there is a procedure for patient information.
Breast Cancer Res. 2022;24(87) © 2022 BioMed Central, Ltd.
Copyright to this article is held by the author(s), licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original citation.